Vontobel Holding Ltd. Cuts Stake in Cigna Group $CI

Key Points

• Vontobel Holding Ltd. has decreased its stake in Cigna Group by 4.1%, now holding 22,138 shares worth approximately $7.32 million as per its recent SEC filing.
• Cigna Group reported earnings of $7.20 per share for the last quarter, exceeding analysts' expectations, with a revenue increase of 11% year-over-year to $67.13 billion.
• The company recently paid a quarterly dividend of $1.51 per share, representing a dividend yield of 2.0%, and has a current dividend payout ratio of 32.97%.

Vontobel Holding Ltd. reduced its stake in shares of Cigna Group (NYSE:CI - Free Report) by 4.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,138 shares of the health services provider's stock after selling 955 shares during the quarter. Vontobel Holding Ltd.'s holdings in Cigna Group were worth $7,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Flaharty Asset Management LLC purchased a new position in shares of Cigna Group in the first quarter valued at $28,000. 1248 Management LLC purchased a new position in shares of Cigna Group in the first quarter valued at $29,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC grew its holdings in shares of Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock valued at $33,000 after purchasing an additional 43 shares in the last quarter. Finally, Saudi Central Bank bought a new stake in Cigna Group in the first quarter worth $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of NYSE CI opened at $301.00 on Friday. The business's 50 day moving average price is $294.68 and its 200 day moving average price is $309.31. The firm has a market cap of $80.35 billion, a P/E ratio of 16.43, a P/E/G ratio of 0.90 and a beta of 0.45. Cigna Group has a 52 week low of $256.89 and a 52 week high of $358.88. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the company posted $6.72 earnings per share. Cigna Group's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group's dividend payout ratio is presently 32.97%.

Insider Activity at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the company's stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company's stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CI. Cantor Fitzgerald reiterated an "overweight" rating and set a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. Barclays lifted their target price on Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Wells Fargo & Company lifted their target price on Cigna Group from $340.00 to $354.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Finally, Guggenheim reiterated a "buy" rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $372.69.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.